Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Gentamicin Action Pathway
Homo sapiens
Drug Action Pathway
Created: 2013-08-22
Last Updated: 2019-08-16
Gentamicin (also known as Garamycin) is an antibiotic that can be used to treat various bacterial infections by inhibiting bacterial protein synthesis. Gentamicin can bind on bacterial 30S ribosomal subunit protein and 16S rRNA irreversibly to inhibit the formation of mRNA. Since the binding site of gentamicin is the region that interacts with wobble base of anticodon of tRNA, hence, binding will cause misreading of mRNA, which lead to incorrect insertion of amino acids to polypeptide so that the polypeptide is non-functional or toxic. This prevents the bacterial protein synthesis which prevent the growth of the bacteria. Gentamicin is a class of aminoglycosides. Aminoglycosides can effectively against aerobic, Gram-negative bacteria, but it is ineffective against anaerobic bacteria, fungi and viruses.
References
Gentamicin Pathway References
Gentamicin (CPhA monograph). (2009). e-CPS (online version of Compendium of Pharmaceuticals and Specialties). Retrieved July 17, 2009.
Song, K.S. Ribosomal protein synthesis inhibitors. In S. Offermanns, & W. Rosenthal (Eds.). Encyclopedic reference of molecular pharmacology. (2004) p. 827-833. Berlin, Germany: Springer.
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
No Proteins Present
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
No Proteins Present
Settings